Gadoterate Meglumine 65219-0084
Product NDC
65219-0084- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 20, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215304
Need to source Gadoterate Meglumine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gadoterate Meglumine | 376.9 mg/mL |
Drug Class
Gadolinium-based Contrast Agent [EPC]Magnetic Resonance Contrast Activity [MoA]
Packaging Options(1)
10 CARTON in 1 BOX (65219-084-15) / 1 VIAL in 1 CARTON (65219-084-01) / 15 mL in 1 VIAL